Naiyer A Rizvi
10PUBLICATIONS
124CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Nov 18, 2025
Cergutuzumab Amunaleukin in Combination with Atezolizumab in Patients with Carcinoembryonic Antigen-Positive Advanced/Metastatic Solid Tumors.Ignacio Melero, Josep Tabernero, Neeltje Steeghs
|Oct 09, 2024
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do
|Dec 13, 2022
Self-Renewing CD8+ T-cell Abundance in Blood Associates with Response to Immunotherapy.Rohan Maniar, Peter H Wang, Robert S Washburn
|Oct 27, 2022
First-in-human study of an OX40 (ivuxolimab) and 4-1BB (utomilumab) agonistic antibody combination in patients with advanced solid tumors.Omid Hamid, Alberto A Chiappori, John A Thompson
|Dec 23, 2020
A Blood-based Assay for Assessment of Tumor Mutational Burden in First-line Metastatic NSCLC Treatment: Results from the MYSTIC Study.Han Si, Michael Kuziora, Katie J Quinn
|Oct 31, 2020
Somatic HLA Class I Loss Is a Widespread Mechanism of Immune Evasion Which Refines the Use of Tumor Mutational Burden as a Biomarker of Checkpoint Inhibitor Response.Meagan Montesion, Karthikeyan Murugesan, Dexter X Jin
Pageof 2
Frequent Collaborators
4 joint publications
Solange Peters
3 joint publications
Catherine A Shu
3 joint publications
Lee Albacker
3 joint publications
Meagan Montesion
2 joint publications
Justin F Gainor
2 joint publications
Yi Yu
2 joint publications
Ferdinandos Skoulidis
2 joint publications
Joseph C Murray
2 joint publications
Natalie Vokes
2 joint publications
Ana Galan Cobo
